Tiama Inspection Worldwide has acquired Dutch firm Vimec, a company with 30 years of experience in the field of non-moulded glass control & inspection for the pharmaceutical industry segment.
Eindhoven-based Vimec has developed expertise in controlling vials, ampoules, syringes, and cartridges at different steps of their production thanks to its machine vision solutions.
Most recently, Vimec has been providing dedicated services for the inspection of vials used for the COVID-19 vaccine.
Tiama’s objectives are to speed up Vimec’s growth by developing synergies (R&D, purchasing, etc.) and increasing Vimec’s sales and services presence to a worldwide level.
Tiama says it also plans to bring technologies it has already developed for food & beverage glass defect recognition (artificial intelligence, deep learning, etc.) to this pharmaceutical segment.